Logo image of EVEX

EVE HOLDING INC (EVEX) Stock Fundamental Analysis

NYSE:EVEX - US29970N1046 - Common Stock

4.04 USD
-0.11 (-2.65%)
Last: 8/27/2025, 8:04:01 PM
4.05 USD
+0.01 (+0.25%)
Pre-Market: 8/28/2025, 4:14:15 AM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to EVEX. EVEX was compared to 68 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of EVEX have multiple concerns. EVEX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year EVEX has reported negative net income.
In the past year EVEX has reported a negative cash flow from operations.
In the past 5 years EVEX always reported negative net income.
In the past 5 years EVEX always reported negative operating cash flow.
EVEX Yearly Net Income VS EBIT VS OCF VS FCFEVEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

EVEX has a Return On Assets of -72.78%. This is amonst the worse of the industry: EVEX underperforms 86.76% of its industry peers.
The Return On Equity of EVEX (-1413.86%) is worse than 85.29% of its industry peers.
Industry RankSector Rank
ROA -72.78%
ROE -1413.86%
ROIC N/A
ROA(3y)-50.36%
ROA(5y)-1976.96%
ROE(3y)-83.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EVEX Yearly ROA, ROE, ROICEVEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EVEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EVEX Yearly Profit, Operating, Gross MarginsEVEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, EVEX has more shares outstanding
The number of shares outstanding for EVEX has been increased compared to 5 years ago.
The debt/assets ratio for EVEX is higher compared to a year ago.
EVEX Yearly Shares OutstandingEVEX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EVEX Yearly Total Debt VS Total AssetsEVEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

EVEX has an Altman-Z score of -1.88. This is a bad value and indicates that EVEX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.88, EVEX is not doing good in the industry: 82.35% of the companies in the same industry are doing better.
EVEX has a Debt/Equity ratio of 11.46. This is a high value indicating a heavy dependency on external financing.
EVEX has a Debt to Equity ratio of 11.46. This is amonst the worse of the industry: EVEX underperforms 85.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 11.46
Debt/FCF N/A
Altman-Z -1.88
ROIC/WACCN/A
WACCN/A
EVEX Yearly LT Debt VS Equity VS FCFEVEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

EVEX has a Current Ratio of 2.77. This indicates that EVEX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.77, EVEX is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
A Quick Ratio of 2.77 indicates that EVEX has no problem at all paying its short term obligations.
EVEX has a Quick ratio of 2.77. This is amongst the best in the industry. EVEX outperforms 83.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.77
Quick Ratio 2.77
EVEX Yearly Current Assets VS Current LiabilitesEVEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

0

3. Growth

3.1 Past

EVEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.68%.
EPS 1Y (TTM)-34.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-63.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, EVEX will show a decrease in Earnings Per Share. The EPS will decrease by -1.22% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-46.02%
EPS Next 2Y-13.18%
EPS Next 3Y-5.24%
EPS Next 5Y-1.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EVEX Yearly Revenue VS EstimatesEVEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
EVEX Yearly EPS VS EstimatesEVEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

EVEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVEX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVEX Price Earnings VS Forward Price EarningsEVEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EVEX Per share dataEVEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

EVEX's earnings are expected to decrease with -5.24% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.18%
EPS Next 3Y-5.24%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EVEX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVE HOLDING INC

NYSE:EVEX (8/27/2025, 8:04:01 PM)

Premarket: 4.05 +0.01 (+0.25%)

4.04

-0.11 (-2.65%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners4.87%
Inst Owner Change-1.12%
Ins Owners0.41%
Ins Owner Change0.16%
Market Cap1.22B
Analysts80
Price Target7.5 (85.64%)
Short Float %12.2%
Short Ratio7.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.9%
Min EPS beat(2)-27.33%
Max EPS beat(2)-10.47%
EPS beat(4)2
Avg EPS beat(4)-1.9%
Min EPS beat(4)-27.33%
Max EPS beat(4)15.97%
EPS beat(8)6
Avg EPS beat(8)10.31%
EPS beat(12)9
Avg EPS beat(12)5.58%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.25%
PT rev (3m)19.19%
EPS NQ rev (1m)-4.88%
EPS NQ rev (3m)-1.18%
EPS NY rev (1m)-4.79%
EPS NY rev (3m)-9.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 90.47
P/tB 90.47
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.61
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -72.78%
ROE -1413.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.36%
ROA(5y)-1976.96%
ROE(3y)-83.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 11.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1859.34%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.77
Quick Ratio 2.77
Altman-Z -1.88
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1505.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-63.85%
EPS Next Y-46.02%
EPS Next 2Y-13.18%
EPS Next 3Y-5.24%
EPS Next 5Y-1.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-26.08%
EBIT Next 3Y5.8%
EBIT Next 5Y20.39%
FCF growth 1Y-81.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-75.76%
OCF growth 3YN/A
OCF growth 5YN/A